Additionally, GALP enhances insulin sensitivity in adipose tissue and skeletal muscle, and its downregulation may contribute to glucose metabolism disorders, thereby increasing GDM susceptibility (53). The gene discussed is GALP; the disease is glucose metabolism disease.